XML 52 R40.htm IDEA: XBRL DOCUMENT
v3.25.2

Revenue Recognition (Details) $ / shares in Units, $ in Thousands | 1 Months Ended | 3 Months Ended | 6 Months Ended |  |
--- | --- | --- | --- | --- | ---
Mar. 31, 2023 USD ($) item | Feb. 28, 2019 USD ($) | Jun. 30, 2025 USD ($) $ / shares | Jun. 30, 2024 USD ($) $ / shares | Jun. 30, 2025 USD ($) $ / shares | Jun. 30, 2024 USD ($) $ / shares | Dec. 31, 2024 USD ($) | Dec. 31, 2023 USD ($)
Increased (decreased) revenues |  |  |  |  | $ (5,800) | $ (5,200) |  |
(Increased) decreased net loss |  |  |  |  | $ (5,800) | $ (5,200) |  |
(Increased) decreased net loss per share | $ / shares |  |  |  |  | $ (0.04) | $ (0.04) |  |
Other assets |  |  | $ 41,118 |  | $ 41,118 |  | $ 36,720 |
Deferred revenue |  |  | 38,052 | $ 36,783 | $ 38,052 | $ 36,783 | 36,592 | $ 35,740
Product |  |  |  |  |  |  |  |
Approximate percentage of revenue collected within 9 months |  |  |  |  | 90.00% |  |  |
Billing collection period (in months) |  |  |  |  | 9 months |  |  |
Extended billing collection period (in months) |  |  |  |  | 6 months |  |  |
Increased (decreased) revenues |  |  | (3,100) | (3,400) |  |  |  |
(Increased) decreased net loss |  |  | $ (3,100) | $ (3,400) |  |  |  |
(Increased) decreased net loss per share | $ / shares |  |  | $ (0.02) | $ (0.03) |  |  |  |
Tests delivered in prior periods that were fully collected |  |  |  |  |  |  |  |
Increased (decreased) revenues |  |  | $ 45,300 | $ 39,900 | $ 79,600 | 73,700 |  |
(Increased) decreased net loss |  |  | $ 45,300 | $ 39,900 | $ 79,600 | $ 73,700 |  |
(Increased) decreased net loss per share | $ / shares |  |  | $ 0.33 | $ 0.32 | $ 0.59 | $ 0.6 |  |
Amounts not refunded to insurance carriers |  |  |  |  |  |  |  |
Increased (decreased) revenues |  |  | $ 400 | $ 600 | $ 900 | $ 4,100 |  |
(Increased) decreased net loss per share | $ / shares |  |  | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.03 |  |
BGI Genomics |  |  |  |  |  |  |  |
Revenue recognized |  | $ 44,000 |  |  |  |  |  |
Agreement term |  | 10 years |  |  |  |  |  |
Revenue, remaining performance obligation |  | $ 6,000 |  |  |  |  |  |
Transaction price |  | 50,000 |  |  |  |  |  |
Deferred revenue |  |  | $ 17,000 |  | $ 17,000 |  | $ 17,300 |
Prepaid royalties |  | $ 20,000 |  |  |  |  |  |
BGI Genomics | License and related development services |  |  |  |  |  |  |  |
Number of performance obligations | item | 2 |  |  |  |  |  |  |
Revenue, remaining performance obligation | $ 24,000 |  |  |  |  |  |  |
BGI Genomics | Oncology assay interpretation services |  |  |  |  |  |  |  |
Revenue recognized |  |  |  |  | $ 300 | $ 100 |  |
Revenue, remaining performance obligation |  |  |  |  |  |  |  | $ 20,000

X
- Definition Period the agreement term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | ntra_AgreementTerm
Namespace Prefix: | ntra_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the agreement transaction price. + References No definition available. + Details
Name: | ntra_AgreementTransactionPrice
Namespace Prefix: | ntra_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Approximate percentage of revenue collected within 9 months. + References No definition available. + Details
Name: | ntra_ApproximatePercentageOfRevenueCollectedWithinNineMonths
Namespace Prefix: | ntra_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the average collection period for billing. + References No definition available. + Details
Name: | ntra_BillingAverageCollectionPeriod
Namespace Prefix: | ntra_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the extended collection period for billing. + References No definition available. + Details
Name: | ntra_ExtendedBillingCollectionPeriod
Namespace Prefix: | ntra_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase (decrease) in the portion of profit or loss for the period, net of income taxes. + References No definition available. + Details
Name: | ntra_IncreaseDecreaseNetIncomeLoss
Namespace Prefix: | ntra_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of increase (decrease) in net income (loss) per share during the reporting period. + References No definition available. + Details
Name: | ntra_IncreaseDecreaseNetIncomeLossPerShare
Namespace Prefix: | ntra_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase (decrease) in revenues during the reporting period. + References No definition available. + Details
Name: | ntra_IncreaseDecreaseRevenues
Namespace Prefix: | ntra_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of performance obligations that have not been recognized as revenue. + References No definition available. + Details
Name: | ntra_NumberOfPerformanceObligations
Namespace Prefix: | ntra_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2 + Details
Name: | us-gaap_ContractWithCustomerLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8 + Details
Name: | us-gaap_ContractWithCustomerLiabilityRevenueRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of noncurrent assets classified as other. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_OtherAssetsNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of asset related to consideration paid in advance for royalties that provide economic benefits within a future period of one year or the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (g)(5) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 340 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 340 -SubTopic 10 -Name Accounting Standards Codification -Section 05 -Paragraph 5 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5 + Details
Name: | us-gaap_PrepaidRoyalties
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of transaction price allocated to performance obligation that has not been recognized as revenue. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -SubTopic 10 -Topic 606 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13 + Details
Name: | us-gaap_RevenueRemainingPerformanceObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ProductMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=ntra_TestsDeliveredInPriorPeriodsThatWereFullyCollectedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=ntra_AmountsNotRefundedToInsuranceCarriersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=ntra_BgiGenomicsCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=ntra_LicenseAndRelatedDevelopmentServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=ntra_OncologyAssayInterpretationServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |